DONATE

IBEC strengthens its international leadership with the HE-mPOwer project

The Institute for Bioengineering of Catalonia (IBEC) has received funding through the Spanish State Research Agency’s 2025 call for proposals for the preparation and management of European projects and attraction of international talent. This funding will allow IBEC to launch the HE-mPOwer project, a strategic initiative designed to strengthen the institute’s internationalisation and increase its competitiveness within the Horizon Europe programme.

Berlin Hosts the Mid-Term Meeting and First Workshop of the SPM4.0 Network coordinated by IBEC

The SPM4.0 consortium convened at Charité–Berlin for its first training workshop and mid-term meeting, reinforcing scientific collaboration and supporting the development of the project’s doctoral researchers. The sessions offered a comprehensive overview of ongoing scientific progress and future training activities. This milestone moment further strengthened coordination across the network and set the pace for upcoming project objectives.

IBEC receives funding from the prestigious Human Frontier Science Program

Illustration of a human cancer cell

The Institute for Bioengineering of Catalonia (IBEC) is participating in the international SOLFEGE project, which aims to explore how different cell types coordinate with each other through soluble factors in the tumour microenvironment. This project has been made possible thanks to funding from the Human Frontier Science Program. SOLFEGE is a consortium led by the German Cancer Research Center (DKFZ), with IBEC and the Duke University, as partners.

Organ-on-Chips to reduce animal testing

IBEC is one of the partners in the ambitious European project UNLOOC, a public-private collaboration involving 51 organisations from 10 countries with a budget of €68 million. The consortium aims to develop Organ-on-Chips technologies to reduce the use of animals in drug development and testing, and to improve the accuracy and personalisation of medical treatments.

nAngioDerm participated in world congress TERMIS

Professor Elisabeth Engel from IBEC, coordinator of nAngioDerm European project, presented the advances of the project at the 6th world congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS2021). Professor Engel talked about cells-materials interactions to promote vascularization in one of the most important scientific conferences in the field of tissue engineering and regenerative medicine.

Last advances of European nanomedicine against malaria explained in a new video

Malaria kills over 500,000 people every year. In the last three years, researchers within the NANOpheles Project worked on the development of nanovectors targeting Plasmodium parasites in the mosquito vector. Xavier Fernàndez-Busquets, coordinator of the EU-funded project, explains their advances in a new video.